Compare Across Protocol (ACX) vs Bio Protocol (BIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Across Protocol vs Bio Protocol — how do they compare? Across Protocol trades at Rp744.61 (market cap Rp525,56M, Rp27,22M 24h volume), while Bio Protocol trades at Rp495.81 (market cap Rp1,11T, Rp306,46M 24h volume). The key difference: Bio Protocol is far larger — about 2112× Across Protocol 's market cap, and Across Protocol 's circulating supply is 704,7M / 1B ACX (71%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 54 Days and Bio Protocol for 16 Days on average.
| ACX | BIO | |
|---|---|---|
Market Cap | Rp525,56M | Rp1,11T |
Volume (24h) | Rp27,22M | Rp306,46M |
Circulating Supply | 704,7M / 1B ACX (71%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 54 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp741.83 with a bearish technical signal, showing sell pressure from moving averages while oscillators remain neutral. The token is currently testing support near Rp731 with resistance at Rp756. With 71% of the 1 million max supply in circulation and an average hold time of 54 days, the token shows moderate distribution stability despite current bearish momentum.
The overall outlook remains cautious due to strong bearish technical indicators, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in cross-chain bridging, while major risks involve low liquidity (Rp522.31M market cap) and crypto market volatility. Investors should monitor support levels for potential entry points.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Across Protocol
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
